drugset / Trial / NCT01126099
Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease
Completed
20 enrolled
Seattle Institute for Biomedical and Clinical Research
National Institute on Aging (NIA) · collabVA Puget Sound Health Care System · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A study of outpatient participants with Alzheimer's disease or a related dementia who have difficult behaviors that are upsetting for them or their caregivers. Prazosin is a medication that is commonly used to treat people with high blood pressure. Research with prazosin has shown that it may be effective in treating behavioral problems by reducing excess adrenalin effects in the brain.
Timeline
- Start
- 2010-03
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prazosin | Unknown | 4 mg | — |